-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Hypersensitivity Reaction
- Literature Citations for the Etiology and Diagnosis of Hypersensitivity Reaction in HIV-Infected Patients (Regularly Updated)
From U.S. National Institutes of Health - Literature Citations for the Management of Hypersensitivity Reaction in HIV-Infected Patients (Regularly Updated)
From U.S. National Institutes of Health - Literature Citations for the Etiology and Diagnosis of Hypersensitivity Reaction in HIV-Infected Patients (Regularly Updated)
From U.S. National Institutes of Health - Literature Citations for the Management of Hypersensitivity Reaction in HIV-Infected Patients (Regularly Updated)
From U.S. National Institutes of Health - Black or White, Ziagen Hypersensitivity Test Works Equally Well, Study Finds (April 1, 2008)
From aidsmap.com - Can HLA-B*5701 Testing Help Avoid Abacavir Hypersensitivity Reaction? (July 25, 2007)
Avoiding abacavir hypersensitivity reaction may be as easy as screening for the HLA-B*5701 allele in any HIV-infected, abacavir-naive patient for whom abacavir therapy is being considered. Graeme Moyle, M.D., reports.
In 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO - HLA Testing for Abacavir Hypersensitivity (July 25, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO - "Patch" Test for Abacavir Hypersensitivity (July 23, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO - Momentum for HLA-B*5701 Testing to Prevent Abacavir Hypersensitivity Grows (November 16, 2006)
In 8th International Congress on Drug Therapy in HIV Infection - Abacavir Hypersensitivity Becoming Easier to Predict Using Pharmacogenetic Markers (August 16, 2006)
In XVI International AIDS Conference - Abacavir Hypersensitivity: Could the Trigger Be in Your Genes? (May 2, 2006)
From aidsmap.com - Low Incidence of Abacavir Hypersensitivity Reaction in Treatment-Naive and -Experienced Patients (July 26, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment - Severity and Rate of Abacavir Hypersensitivity Reactions Higher Than Previously Believed (February 23, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Abacavir Hypersensitivity Reaction Predicted by Genetic Test (March 26, 2004)
Research in Australia suggests the experimental test could drastically reduce hypersensitivity reactions, but is prone to false positives.
In AIDS Treatment News, from AIDS Treatment News - Clinical Risk Factors for Hypersensitivity Reactions to Abacavir: Side Effects of Antiretroviral Therapy (September 17, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - Secondary Syphilis and Abacavir Hypersensitivity Reaction (October 26, 2002)
In 40th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO - HLA-B57 and TNF-Alpha Variants Associated With Hypersensitivity Reactions to Abacavir Among HIV-1-Positive Subjects (February 27, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - The Presence of HLA-B*5701, -DRB1*0701, and -DQ3 Is Highly Predictive of Hypersensitivity to the HIV Reverse Transcriptase Inhibitor Abacavir (February 27, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Comparison of Symptoms of Influenza A Infection With Abacavir-Associated Hypersensitivity Reaction (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Epidemiological Risk Factors and Immunological Mechanisms of Hypersensitivity Reactions to Abacavir (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
  |